Andrew Stephen John
About Andrew Stephen John
Andrew Stephen John is a Product Manager at BoomerangFX in Ontario, Canada, with three years of experience in this role since 2021. He has a diverse background in quality assurance, operations, and distribution, having worked for several companies in Canada and India.
Work at BoomerangFX
Andrew Stephen John has been serving as a Product Manager at BoomerangFX since 2021. In this role, he is responsible for overseeing product development and management processes. His tenure at BoomerangFX has spanned three years, during which he has contributed to various projects and initiatives aimed at enhancing product offerings and user experience.
Previous Employment Experience
Before joining BoomerangFX, Andrew worked at Covalon Technologies Ltd. as an Operational Specialist from 2020 to 2021. He also held the position of Distribution Specialist at Mister Safety Shoes Inc. from 2019 to 2020. His earlier experience includes serving as Sr. Quality Assurance at LifeCell International Pvt. Ltd. from 2015 to 2017 and as Officer - Quality and Operations at Vibrant Farmer from 2017 to 2019.
Education and Expertise
Andrew holds a Master of Engineering Science (MEngSc) in Biopharmaceutical Engineering from University College Dublin, which he completed from 2007 to 2009. He also studied Biotechnology at Anna University, earning a B.Tech degree from 2013 to 2014. Additionally, he completed a Product Management program at Product School from 2009 to 2013. His educational background supports his expertise in product development and management.
Skills and Specializations
Andrew possesses skills in data munging, which involves cleaning and transforming raw data for analysis. He has expertise in creating UML diagrams and wireframing screens, essential components of the product development process. His experience includes conducting extensive marketing research to support product development and strategic decision-making.
Thesis Project and Research
As part of his academic pursuits, Andrew developed a comprehensive thesis project focused on designing a Bio-Pharmaceutical Plant from scratch. This project included feasibility assessments for large-scale monoclonal antibody production, safety and loss prevention strategies, and considerations for process economics.